On March 25, 2026, 8,398,300 common shares were disposed of at 2,435.5 yen per share, totaling 20,454,059,650 yen, to The Master Trust Bank of Japan, introducing an ESOP trust for stock grants.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4528","jir_company_name":"Ono Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4528-20260305-02.pdf","jir_short_summary":"On March 25, 2026, 8,398,300 common shares were disposed of at 2,435.5 yen per share, totaling 20,454,059,650 yen, to The Master Trust Bank of Japan, introducing an ESOP trust for stock grants.","jir_summary":"### Overview of Capital Policy\nOno Pharmaceutical Co., Ltd. resolved at its board meeting on March 5, 2026, to dispose of treasury stock by third-party allotment. The number of shares disposed is 8,398,300 common shares at a disposal price of 2,435.5 yen per share, totaling 20,454,059,650 yen, to The Master Trust Bank of Japan, Ltd. (stock grant ESOP trust account). This disposal is associated with the introduction of a long-term incentive stock compensation scheme for employees of its U.S. subsidiary, Deciphera Pharmaceuticals, Inc., through an ESOP trust. The trust agreement is scheduled to be executed on March 23, 2026.\n\n### Impact and Procedures for Shareholders\nThe number of shares disposed represents a 1.68% dilution against the total issued shares of 498,692,800, with minimal anticipated impact on the stock market. The disposal price was calculated based on the closing price as of March 4, 2026, and all statutory auditors recognized the price as reasonable. Furthermore, since the dilution rate is below 25% and there is no change in controlling shareholders, neither an independent third-party opinion from the Tokyo Stock Exchange nor shareholder consent procedures are required. The trust period is planned from March 23, 2026, to March 31, 2029, with voting rights exercised according to instructions from the trust administrator.","jir_financial_highlights":"Number of Shares Disposed: 8,398,300 shares (Unknown)\nDisposal Price: 2,435.5 yen per share (Unknown)\nTotal Disposal Amount: 20,454,059,650 yen (Unknown)\nDilution Rate: 1.68% (against 498,692,800 total issued shares) (Unknown)","jir_category":"","jir_hashtags":"#OnoPharmaceutical, #CapitalPolicy, #DisposalOfTreasuryStock","jir_key_figures":"Number of Shares Disposed: 8,398,300 shares\nDisposal Price: 2,435.5 yen per share\nTotal Disposal Amount: 20,454,059,650 yen","jir_meta_title":"Ono Pharmaceutical Co., Ltd. Disposes of 8,398,300 Treasury Shares for 20.454 Billion Yen via Third-Party Allotment","jir_meta_description":"Ono Pharmaceutical Co., Ltd. will dispose of 8,398,300 treasury shares at 2,435.5 yen per share on March 25, 2026, introducing an ESOP trust for employees of its U.S. subsidiary. Dilution rate is 1.68% with minimal market impact.","jir_og_title":"Ono Pharmaceutical Co., Ltd. Announces Introduction of ESOP Trust through Disposal of Treasury Stock","jir_og_description":"Disposing of 8,398,300 treasury shares by third-party allotment to implement a long-term employee incentive scheme. Dilution rate is 1.68% with limited impact on the market.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7530,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-33298","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n